Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.
about
NF-E2-related factor 2 regulates the stress response to UVA-1-oxidized phospholipids in skin cells.Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skinSystemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and MetastasisThe peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes.Epidermal platelet-activating factor receptor activation and ultraviolet B radiation result in synergistic tumor necrosis factor-alpha production.Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists.Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands.Mice lacking epidermal PPARγ exhibit a marked augmentation in photocarcinogenesis associated with increased UVB-induced apoptosis, inflammation and barrier dysfunctionSystemic chemotherapy is modulated by platelet-activating factor-receptor agonists.The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.Platelet-Activating Factor-Receptor and Tumor Immunity.Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.Radiation therapy generates platelet-activating factor agonistsPotential Contributions of Antioxidants to Cancer Therapy.Feeding a Mixture of Choline Forms during Lactation Improves Offspring Growth and Maternal Lymphocyte Response to Ex Vivo Immune Challenges.Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse.
P2860
Q28392832-B78625F5-A4E0-4116-A21D-32A8DF8F3B71Q28544768-09C877DF-227B-4871-ACCF-B18E7BBF6D05Q33826633-F50C918B-9918-4DEA-8CE6-AC559F8BE2C3Q33865064-7F6408AC-2AAD-46DE-A606-EE28B48103F7Q33872427-DDB82A73-809A-4ABC-B81C-7FCD75C0A82FQ34020597-6B085669-8472-4478-8C54-6355D87C37E7Q34149803-972B7B37-B756-43E5-A475-97221EC7523DQ34613089-CFFD5165-9A93-4AB3-A83F-E695B59C761CQ34716311-5DE412EC-BDA3-4580-B8AF-CC06EBF1D4F5Q34794625-656458C7-147A-4009-A5BA-3B9B73A2D5EBQ35438088-001778E0-0790-4060-91C6-B2A8EED45136Q36118884-A933A048-BDB7-4C03-92CA-48DFE6B49C66Q36625266-7CE154F4-0C3B-4258-884D-752DAA73222BQ36935937-82352D34-F28B-485C-B7D0-156EA70960A5Q37156655-1114D434-0834-43C6-A96E-126327291504Q37190440-30504D4E-BD8F-4B6A-9647-2AB417B9F6E6Q39382149-85887943-CF1B-4A29-9F83-AB29CA328C46Q41195202-AADC1DDE-939E-4E75-A0CE-5C681C8C50B9Q47139765-74F46643-4978-4A5E-8586-BF1209839BCE
P2860
Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Oxidized glycerophosphocholine ...... et radiation-mediated effects.
@ast
Oxidized glycerophosphocholine ...... et radiation-mediated effects.
@en
type
label
Oxidized glycerophosphocholine ...... et radiation-mediated effects.
@ast
Oxidized glycerophosphocholine ...... et radiation-mediated effects.
@en
prefLabel
Oxidized glycerophosphocholine ...... et radiation-mediated effects.
@ast
Oxidized glycerophosphocholine ...... et radiation-mediated effects.
@en
P2093
P2860
P1476
Oxidized glycerophosphocholine ...... let radiation-mediated effects
@en
P2093
Gopal K Marathe
Qiwei Zhang
Raymond L Konger
Yongxue Yao
P2860
P356
10.1016/J.PROSTAGLANDINS.2008.04.002
P577
2008-05-02T00:00:00Z